Changes in Body Composition with Ritonavir-Boosted and Unboosted Atazanavir Treatment in Combination with Lamivudine and Stavudine: A 96-Week Randomized, Controlled Study

被引：23

作者：

McComsey, Grace ^{[1
,2
]}

Rightmire, Anna ^{[3
]}

Wirtz, Victoria ^{[3
]}

Yang, Rong ^{[3
]}

Mathew, Marina ^{[3
]}

McGrath, Donnie ^{[3
]}

机构：

[1] Case Western Reserve Univ, Div Pediat Infect Dis & Rheumatol, Dept Pediat, Cleveland, OH 44106 USA

[2] Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA

[3] Bristol Myers Squibb Co, Res & Dev, Wallingford, CT 06492 USA

来源：

CLINICAL INFECTIOUS DISEASES | 2009年 / 48卷 / 09期

关键词：

ANTIRETROVIRAL THERAPY; NAIVE SUBJECTS; LIPODYSTROPHY; EFAVIRENZ; MEN; FAT;

D O I：

10.1086/597776

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

This 96-week, open-label, randomized study assessed changes in body composition in treatment-naive patients infected with human immunodeficiency virus type 1 who were treated with either atazanavir or ritonavir-boosted atazanavir, in combination with stavudine and lamivudine. Both treatment groups had similar increases in trunk fat, but patients treated with ritonavir-boosted atazanavir had a significantly lower incidence of lipoatrophy.

引用

页码：1323 / 1326

页数：4

共 12 条

[1] Glucose metabolism, lipid, and body fat changes in antiretroviral-naive subjects randomized to nelfinavir or efavirenz plus dual nucleosides [J].

Dubé, MP ;

Parker, RA ;

Tebas, P ;

Grinspoon, SK ;

Zackin, RA ;

Robbins, GK ;

Roubenoff, R ;

Shafer, RW ;

Wininger, DA ;

Meyer, WA ;

Snyder, SW ;

Mulligan, K .

AIDS, 2005, 19 (16) :1807-1818

[2] Gender differences in antiretroviral drug-related adipose tissue alterations - Women are at higher risk than men and develop particular lipodystrophy patterns [J].

Galli, M ;

Veglia, F ;

Angarano, G ;

Santambrogio, S ;

Meneghini, E ;

Gritti, F ;

Cargnel, A ;

Mozzotta, F ;

Lazzarin, A .

JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2003, 34 (01) :58-61

[3]

HAUBRICH RH, 2007, 14 C RETR OPP INF LO

[4] Body fat and other metabolic effects of atazanavir and efavirenz, each administered in combination with zidovudine plus lamivudine, in antiretroviral-naive HIV-infected patients [J].

Jemsek, JG ;

Arathoon, E ;

Arlotti, M ;

Perez, C ;

Sosa, N ;

Pokrovskiy, V ;

Thiry, A ;

Soccodato, M ;

Noor, MA ;

Giordano, M .

CLINICAL INFECTIOUS DISEASES, 2006, 42 (02) :273-280

[5]

Mallon PWG, 2007, AIDS REV, V9, P3

[6] Prospective evaluation of the effects of antiretroviral therapy on body composition in HIV-1-infected men starting therapy [J].

Mallon, PWG ;

Miller, J ;

Cooper, DA ;

Carr, A .

AIDS, 2003, 17 (07) :971-979

[7]

MCGRATH D, 2007, 14 C RETR OPP INF LO

[8]

MOYLE G, 2007, 11 EUR AIDS C MADR

[9] Dose-ranging, randomized, clinical trial of atazanavir with lamivudine and stavudine in anti retroviral-naive subjects: 48-week results [J].

Murphy, RL ;

Sanne, I ;

Cahn, P ;

Phanuphak, P ;

Percival, L ;

Kelleher, T ;

Giordano, M .

AIDS, 2003, 17 (18) :2603-2614

[10]

Malan DR, 2008, JAIDS-J ACQ IMM DEF, V47, P161, DOI 10.1097/QAI.0b013e31815ace6a

← 1 2 →